Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec;26(6):556-562.
doi: 10.1097/MCC.0000000000000777.

Biomarker-guided management of acute kidney injury

Sandra L Kane-Gill  1   2 , Melanie Meersch  3 , Max Bell  4   5
Affiliations
Review

Biomarker-guided management of acute kidney injury

Sandra L Kane-Gill et al. Curr Opin Crit Care. 2020 Dec.

Abstract

Purpose of review: The current narrative review discusses practical applications of stress and damage biomarkers for the management of acute kidney injury (AKI) based on clinical trials and real-world evaluations.

Recent findings: In 2013 with the discovery and validation study of biomarkers for AKI (Sapphire) advancement in care was provided allowing for the early identification of patients at high risk for developing AKI. It was the combination of new biomarkers and the Kidney Disease Improving Global Outcomes (KDIGO) guidelines for managing patients with AKI that provided an opportunity to improve patient care. In 2017, the PrevAKI study implemented KDIGO guideline management in high-risk patients identified by biomarkers followed in 2018 with the BigPAK study that used a similar approach, both of which demonstrated positive outcomes in patient care. Next, real-world evaluations followed supporting biomarker guided management of AKI in clinical practice. Also, proposals for better nephrotoxin management, a major modifiable exposure to prevent AKI, were provided with the foresight in identifying high-risk patients.

Summary: Stress and damage biomarker-based approaches to patient care seem to be promising for identifying patients at high risk for developing AKI and thus offers an opportunity for early management to prevent and ameliorate AKI and drug-associated AKI.

PubMed Disclaimer

References

    1. Murugan R, Karajala-Subramanyam V, Lee M, et al. Acute kidney injury in nonsevere pneumonia is associated with an increased immune response and lower survival. Kidney Int 2010; 77:527–535.
    1. Sileanu FE, Murugan R, Lucko N, et al. AKI in low-risk versus high-risk patients in intensive care. Clin J Am Soc Nephrol 2015; 10:187–196.
    1. Haines RW, Zolfaghari P, Wan Y, et al. Elevated urea-to-creatinine ratio provides a biochemical signature of muscle catabolism and persistent critical illness after major trauma. Intensive Care Med 2019; 45:1718–1731.
    1. Ravn B, Prowle JR, Martensson J, et al. Superiority of serum cystatin C over creatinine in prediction of long-term prognosis at discharge from ICU. Crit Care Med 2017; 45:e932–e940.
    1. Kashani KB, Frazee EN, Kukralova L, et al. Evaluating muscle mass by using markers of kidney function: development of the sarcopenia index. Crit Care Med 2017; 45:e23–e29.

Publication types

LinkOut - more resources